
<!DOCTYPE html>
<html lang="en" dir="ltr" prefix="og: https://ogp.me/ns#">
  
<!-- Mirrored from investors.scholarrock.com/node/8336/html by HTTrack Website Copier/3.x [XR&CO'2014], Sat, 21 Dec 2024 12:10:20 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=UTF-8" /><!-- /Added by HTTrack -->
<head>
    <title>SEC Filing - Scholar Rock, Inc.</title>
    <meta name="robots" content="noindex">
    <link rel="stylesheet" media="all" href="../../sites/g/files/knoqqb56236/files/css/css_-Ogun-b4Vwq8nD6qwBoEYuBhEF_0grnAaUrH4akFvLUcd37.css?delta=0&amp;language=en&amp;theme=nir_pid2662&amp;include=eJyNjEEKgDAMBD8k9UkhTQMGSiJNRfp7ayuePHjK7jAblQIRnVdnAq8tsy_a2cnRpTKoVSH29YOF5w5__LiDkOlEqJhbN-b4bQGTRYaMh9L2Q9yLpQuf0kIl" />

    
    <!-- IrwinIQ Tag Manager --> <script> (function(w,d){ var _mtm = w._mtm = w._mtm || []; _mtm.push({'mtm.startTime': (new Date().getTime()), 'event': 'mtm.Start'}); var g=d.createElement('script'), s=d.getElementsByTagName('script')[0]; g.async=true; g.src='../../../analytics.imirwin.com/js/container_XFyWYf0m.js'; s.parentNode.insertBefore(g,s); })(window, document); </script> <!-- End IrwinIQ Tag Manager -->

<!-- Google Tag Manager -->
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'../../../www.googletagmanager.com/gtm5445.html?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-WTGMF33');</script>
<!-- End Google Tag Manager -->

<!-- Google Tag Manager (noscript) -->
<noscript><iframe src="../../../www.googletagmanager.com/nsca0c.html?id=GTM-WTGMF33"
height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<!-- End Google Tag Manager (noscript) -->
  </head>
  <body class="body-sidebars-first nir-node nir-node--type-nir-sec-filing nir-node--8336 page-template-default page page-parent wp-custom-logo wp-embed-responsive full-width-content genesis-breadcrumbs-visible genesis-singular-image-hidden genesis-footer-widgets-visible top-parent-investors-media investors-media has-no-blocks elementor-default elementor-page cbp-spmenu-push cookies-set cookies-accepted body_classes" id="body" cz-shortcut-listen="true">
      <div class="region region-content">
    <div id="block-nir-pid2662-websitenoticeblock" class="block--website-notice-block block--website-notice-block--8336 block--content--website-notice-block block--content--website-notice-block--8336 block--24a64b1d-13aa-4b20-8029-2df59f99a96c block--24a64b1d-13aa-4b20-8029-2df59f99a96c--8336 block block-nir-website-notices block-website-notice-block">
  
    
      
  </div>
<div data-drupal-messages-fallback class="hidden"></div>

<div id="block-nir-pid2662-content" class="block--system-main-block block--system-main-block--8336 block--content--system-main-block block--content--system-main-block--8336 block--c4d2f333-a7f8-46c4-afc3-3e36992b73c0 block--c4d2f333-a7f8-46c4-afc3-3e36992b73c0--8336 block block-system block-system-main-block">
  
    
      <div class="nir-sec-header"><div class="logo"><img src="../../sites/g/files/knoqqb56236/files/Logo.png" alt="Scholar Rock, Inc." />
</div><div class="sec-docs">View:  <div class="file-link">
  <span class="file file--mime-application-rtf file--general"> <a href="../../static-files/0001179110-21-007038.rtf%3b%20filename_%3dUTF-8%27%270001179110-21-007038.rtf" type="application/rtf" title="0001179110-21-007038.rtf">Download DOC</a></span><span class="filesize"> </span>
</div>
  <div class="file-link">
  <span class="file file--mime-application-pdf file--application-pdf"> <a href="../../static-files/0001179110-21-007038.pdf%3b%20filename_%3dUTF-8%27%270001179110-21-007038.pdf" type="application/pdf" title="0001179110-21-007038.pdf">Download PDF</a></span><span class="filesize"> </span>
</div>
  <div class="file-link">
  <span class="file file--mime-application-vnd-ms-excel file--x-office-spreadsheet"> <a href="../../static-files/0001179110-21-007038.xls%3b%20filename_%3dUTF-8%27%270001179110-21-007038.xls" type="application/vnd.ms-excel" title="0001179110-21-007038.xls">Download XLS</a></span><span class="filesize"> </span>
</div>
</div></div>
    <!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>SEC FORM 
            3</title>
<style type="text/css">
              .FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
              .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
              .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
              .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
              .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
              .FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
              .FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
              .FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
              .FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
              .FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
              .FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
              .FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
              .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
              .SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
              .SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
              .MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
              .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
              .FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
              .FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
              .FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
              .SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif; 
              		font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
              .FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
              .CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid;  border-color: black:}
              body {background: white;}
      </style>
</head>
<body>SEC Form 3 
   <table width="100%" border="0" cellspacing="0" cellpadding="4"><tr>
<td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 3</td>
<td rowspan="1" width="60%" valign="middle" align="center">
<span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span>
</td>
<td rowspan="1" width="20%" valign="top" align="center">&nbsp;<table width="100%" border="1" summary="OMB Approval Status Box">
<tr><td class="FormTextC">OMB APPROVAL</td></tr>
<tr><td><table width="100%" border="0" summary="OMB Interior Box">
<tr>
<td class="SmallFormText" colspan="3">OMB Number:</td>
<td class="SmallFormTextR">3235-0104</td>
</tr>
<tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr>
<tr>
<td class="SmallFormText" colspan="3">hours per response:</td>
<td class="SmallFormTextR">0.5</td>
</tr>
</table></td></tr>
</table></td>
</tr></table>
<table width="100%" border="1" cellspacing="0" cellpadding="4">
<tr>
<td rowspan="3" width="30%" valign="top">
<span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="../../../www.sec.gov/cgi-bin/browse-edgarc049?action=getcompany&amp;CIK=0001868114">Ho Junlin</a></td></tr></table>
<hr width="98%">
<table border="0" width="100%"><tr>
<td width="33%" class="MedSmallFormText">(Last)</td>
<td width="33%" class="MedSmallFormText">(First)</td>
<td width="33%" class="MedSmallFormText">(Middle)</td>
</tr></table>
<table border="0" width="100%">
<tr><td><span class="FormData">301 BINNEY STREET</span></td></tr>
<tr><td><span class="FormData"></span></td></tr>
</table>
<hr width="98%">
<span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr>
<td width="33%"><span class="FormData">CAMBRIDGE</span></td>
<td width="33%"><span class="FormData">MA</span></td>
<td width="33%"><span class="FormData">02142</span></td>
</tr></table>
<hr width="98%">
<table border="0" width="100%"><tr>
<td width="33%" class="MedSmallFormText">(City)</td>
<td width="33%" class="MedSmallFormText">(State)</td>
<td width="33%" class="MedSmallFormText">(Zip)</td>
</tr></table>
</td>
<td rowspan="3" width="15%" valign="top">
<span class="MedSmallFormText">2. Date of Event Requiring Statement
         (Month/Day/Year)</span><br><span class="FormData">06/15/2021</span>
</td>
<td valign="top" colspan="2">
<span class="MedSmallFormText">3. Issuer Name <b>and</b> Ticker or Trading Symbol
      </span><br><a href="../../../www.sec.gov/cgi-bin/browse-edgar39a0?action=getcompany&amp;CIK=0001727196">Scholar Rock Holding Corp</a>
     [ <span class="FormData">SRRK</span> ]
   </td>
</tr>
<tr>
<td rowspan="2" width="30%" valign="top">
<span class="MedSmallFormText">4. Relationship of Reporting Person(s) to Issuer
      </span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%">
<tr>
<td width="15%" align="center"></td>
<td width="35%" class="MedSmallFormText">Director</td>
<td width="15%" align="center"></td>
<td width="35%" class="MedSmallFormText">10% Owner</td>
</tr>
<tr>
<td align="center"><span class="FormData">X</span></td>
<td class="MedSmallFormText">Officer (give title below)</td>
<td align="center"></td>
<td class="MedSmallFormText">Other (specify below)</td>
</tr>
<tr><td colspan="4" align="center">
<span class="FormData">General Counsel</span><span class="FormData"></span>
</td></tr>
</table>
</td>
<td valign="top">
<span class="MedSmallFormText">5. If Amendment, Date of Original Filed
         (Month/Day/Year)</span><br>
</td>
</tr>
<tr><td valign="top">
<span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
      </span><table border="0" width="100%">
<tr>
<td width="15%" align="center"><span class="FormData">X</span></td>
<td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td>
</tr>
<tr>
<td width="15%" align="center"></td>
<td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td>
</tr>
</table>
</td></tr>
</table>
<table width="100%" border="1" cellspacing="0" cellpadding="4">
<thead>
<tr><th width="100%" valign="top" colspan="4" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Beneficially Owned</b></th></tr>
<tr>
<th width="44%" valign="top" align="left" class="MedSmallFormText">1. Title of Security (Instr. 
      4)
   </th>
<th width="19%" valign="top" align="left" class="MedSmallFormText">2. 
      Amount of Securities Beneficially Owned (Instr. 
      4)
   </th>
<th width="11%" valign="top" align="left" class="MedSmallFormText">3. Ownership Form: Direct (D) or Indirect (I) (Instr. 
      5)
   </th>
<th width="26%" valign="top" align="left" class="MedSmallFormText">4. Nature of Indirect Beneficial Ownership (Instr. 
      5)
   </th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><span class="FormData">Common Stock</span></td>
<td align="center">
<span class="FormData">11,550</span><span class="FootnoteData"><sup>(1)</sup></span>
</td>
<td align="center"><span class="FormData">D</span></td>
<td align="left"></td>
</tr>
<tr>
<td align="left"><span class="FormData">Common Stock</span></td>
<td align="center">
<span class="FormData">27,083</span><span class="FootnoteData"><sup>(2)</sup></span>
</td>
<td align="center"><span class="FormData">D</span></td>
<td align="left"></td>
</tr>
</tbody>
</table>
<table width="100%" border="1" cellspacing="0" cellpadding="4">
<thead>
<tr><th width="100%" valign="top" colspan="8" align="center" class="FormTextC">
<b>Table II - Derivative Securities Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b>
</th></tr>
<tr>
<th width="35%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Derivative Security (Instr. 
      4)
   </th>
<th width="9%" valign="top" colspan="2" align="left" class="MedSmallFormText">2. Date Exercisable and Expiration Date 
      (Month/Day/Year)</th>
<th width="26%" valign="top" colspan="2" align="left" class="MedSmallFormText">3. Title and Amount of Securities Underlying Derivative Security (Instr. 
      4)
   </th>
<th width="7%" valign="top" rowspan="2" align="left" class="MedSmallFormText">4. Conversion or Exercise Price of Derivative Security
   </th>
<th width="8%" valign="top" rowspan="2" align="left" class="MedSmallFormText">5. Ownership Form: Direct (D) or Indirect (I) (Instr. 
      5)
   </th>
<th width="15%" valign="top" rowspan="2" align="left" class="MedSmallFormText">6. Nature of Indirect Beneficial Ownership (Instr. 
      5)
   </th>
</tr>
<tr>
<th width="4%" valign="bottom" align="center" class="MedSmallFormText">Date Exercisable</th>
<th width="5%" valign="bottom" align="center" class="MedSmallFormText">Expiration Date</th>
<th width="20%" valign="bottom" align="center" class="MedSmallFormText">Title</th>
<th width="6%" valign="bottom" align="center" class="MedSmallFormText">Amount or Number of Shares</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><span class="FormData">Stock Option (Right to Buy)</span></td>
<td align="center">
<span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(3)</sup></span>
</td>
<td align="center"><span class="SmallFormData">04/03/2028</span></td>
<td align="center"><span class="FormData">Common Stock</span></td>
<td align="center"><span class="FormData">42,974</span></td>
<td align="center"><span class="FormData">7.17</span></td>
<td align="center"><span class="FormData">D</span></td>
<td align="left"></td>
</tr>
<tr>
<td align="left"><span class="FormData">Stock Option (Right to Buy)</span></td>
<td align="center">
<span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(4)</sup></span>
</td>
<td align="center"><span class="SmallFormData">05/23/2028</span></td>
<td align="center"><span class="FormData">Common Stock</span></td>
<td align="center"><span class="FormData">7,005</span></td>
<td align="center"><span class="FormData">14</span></td>
<td align="center"><span class="FormData">D</span></td>
<td align="left"></td>
</tr>
<tr>
<td align="left"><span class="FormData">Stock Option (Right to Buy)</span></td>
<td align="center">
<span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(5)</sup></span>
</td>
<td align="center"><span class="SmallFormData">01/31/2029</span></td>
<td align="center"><span class="FormData">Common Stock</span></td>
<td align="center"><span class="FormData">10,125</span></td>
<td align="center"><span class="FormData">15.11</span></td>
<td align="center"><span class="FormData">D</span></td>
<td align="left"></td>
</tr>
<tr>
<td align="left"><span class="FormData">Stock Option (Right to Buy)</span></td>
<td align="center">
<span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(6)</sup></span>
</td>
<td align="center"><span class="SmallFormData">02/06/2030</span></td>
<td align="center"><span class="FormData">Common Stock</span></td>
<td align="center"><span class="FormData">36,550</span></td>
<td align="center"><span class="FormData">13.52</span></td>
<td align="center"><span class="FormData">D</span></td>
<td align="left"></td>
</tr>
<tr>
<td align="left"><span class="FormData">Stock Option (Right to Buy)</span></td>
<td align="center">
<span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(7)</sup></span>
</td>
<td align="center"><span class="SmallFormData">03/23/2030</span></td>
<td align="center"><span class="FormData">Common Stock</span></td>
<td align="center"><span class="FormData">9,400</span></td>
<td align="center"><span class="FormData">14.75</span></td>
<td align="center"><span class="FormData">D</span></td>
<td align="left"></td>
</tr>
<tr>
<td align="left"><span class="FormData">Stock Option (Right to Buy)</span></td>
<td align="center">
<span class="SmallFormData">
                
            </span><span class="FootnoteData"><sup>(8)</sup></span>
</td>
<td align="center"><span class="SmallFormData">02/01/2031</span></td>
<td align="center"><span class="FormData">Common Stock</span></td>
<td align="center"><span class="FormData">38,500</span></td>
<td align="center"><span class="FormData">58.93</span></td>
<td align="center"><span class="FormData">D</span></td>
<td align="left"></td>
</tr>
</tbody>
</table>
<table border="0" width="100%">
<tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr>
<tr><td class="FootnoteData">1. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.  The shares subject to this RSU award will vest and become exercisable annually over four years, subject to a continued service relationship with theIssuer on such vesting date.</td></tr>
<tr><td class="FootnoteData">2. Options exercised and held as common stock.</td></tr>
<tr><td class="FootnoteData">3. 13,136 shares remain unvested under this stock option with one-third vesting quarterly on September 5, 2021, December 5, 2021 and March 5, 2022.</td></tr>
<tr><td class="FootnoteData">4. This option vests quarterly over four (4) years, with the first quarterly amount vesting on August 29, 2018.</td></tr>
<tr><td class="FootnoteData">5. 7,875 shares remain unvested under this stock option with one-seventh vesting quarterly on June 30, 2021, September 30, 2021, December 31, 2021, March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.</td></tr>
<tr><td class="FootnoteData">6. This option vests quarterly over four (4) years, with the first quarterly amount vesting on April 1, 2020.</td></tr>
<tr><td class="FootnoteData">7. This option vests quarterly over four (4) years, with the first quarterly amount vesting on May 1, 2020.</td></tr>
<tr><td class="FootnoteData">8. This option vests quarterly over four (4) years, with the first quarterly amount vesting on April 1, 2021.</td></tr>
</table>
<table width="100%" border="0">
<tr>
<td width="60%"></td>
<td width="20%"><u><span class="FormData">/s/ Junlin Ho</span></u></td>
<td width="20%"><u><span class="FormData">06/25/2021</span></u></td>
</tr>
<tr>
<td></td>
<td class="MedSmallFormText">** Signature of Reporting Person</td>
<td class="MedSmallFormText">Date</td>
</tr>
<tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr>
<tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person, 
                  <i>see</i>

                  Instruction 
                  5

                  (b)(v).</td></tr>
<tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations 
                  <i>See</i>

                  18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr>
<tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, 
                  <i>see</i>

                  Instruction 6 for procedure.</td></tr>
<tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr>
</table>
</body>

<!-- Mirrored from investors.scholarrock.com/node/8336/html by HTTrack Website Copier/3.x [XR&CO'2014], Sat, 21 Dec 2024 12:10:20 GMT -->
</html>
<div><a name="ex24ho.txt"></a></div><PRE>Exhibit 24
LIMITED POWER OF ATTORNEY
       The undersigned hereby constitutes and appoints Laurie
       Burlingame, and any designee thereof, signing singly,
       and with full power of substitution, the undersigned's true and
       lawful attorney-in-fact to:
       (1) execute for and on behalf of the undersigned, in the undersigned's
           capacity as an officer and/or director of Scholar Rock Holding
           Corporation (the "Company"), from time to time the following U.S.
           Securities and Exchange Commission ("SEC") forms: (i) Form ID,
           including any attached documents, to effect the assignment of codes
           to the undersigned to be used in the transmission of information
           to the SEC using the EDGAR System; (ii) Form 3, Initial Statement
           of Beneficial Ownership of Securities, including any attached
           documents; (iii) Form 4, Statement of Changes in Beneficial
           Ownership of Securities, including any attached documents;
           (iv) Form 5, Annual Statement of Beneficial Ownership of Securities
           in accordance with Section 16(a) of the Securities Exchange Act of
           1934, as amended, and the rules thereunder, including any attached
           documents; (v) Schedule 13D, (vi) Schedule 13G and (vii) amendments
           of each thereof, in accordance with the Securities Exchange Act of
           1934, as amended, and the rules thereunder, including any attached
           documents;
       (2) do and perform any and all acts for and on behalf of the undersigned
           which may be necessary or desirable to complete and execute any such
           Form 3, 4 or 5, Schedule 13D, Schedule 13G or any amendment(s)
           thereto, and timely file such form(s) with the SEC and any securities
           exchange, national association or similar authority; and
       (3) take any other action of any type whatsoever in connection with the
           foregoing which, in the opinion of such attorney-in-fact, may be of
           benefit to, in the best interest of, or legally required by, the
           undersigned, it being understood that the documents executed by
           such attorney-in-fact on behalf of the undersigned pursuant to this
           Power of Attorney shall be in such form and shall contain such terms
           and conditions as such attorney-in-fact may approve in such
           attorney-in-fact's discretion.
           The undersigned hereby grants to each such attorney-in-fact, acting
           singly, full power and authority to do and perform any and every act
           and thing whatsoever requisite, necessary or proper to be done in the
           exercise of any of the rights and powers herein granted, as fully to
           all intents and purposes as the undersigned might or could do if
           personally present, with full power of substitution or revocation,
           hereby ratifying and confirming all that such attorney-in-fact, or
           such attorney-in-fact's substitute or substitutes, shall lawfully do
           or cause to be done by virtue of this power of attorney and the
           rights and powers herein granted. The undersigned acknowledges that
           the foregoing attorneys-in-fact, in serving in such capacity at the
           request of the undersigned, are not assuming, nor is the Company
           assuming, any of the undersigned's responsibilities to comply with
           Section 16 or Regulation 13D-G of the Securities Exchange Act of
           1934, as amended.
           The undersigned hereby agrees to indemnify the attorney-in-fact and
           the Company from and against any demand, damage, loss, cost or
           expense arising from any false or misleading information provided
           by the undersigned to the attorney-in-fact.

       This Power of Attorney shall remain in full force and effect until
       the undersigned is no longer required to file such forms with respect
       to the undersigned's holdings of and transactions in securities issued
       by the Company, unless earlier revoked by the undersigned in a signed
       writing delivered to the foregoing attorneys-in-fact. This Power of
       Attorney supersedes any prior power of attorney in connection with the
       undersigned's capacity as an officer and/or director of the Company.
       This Power of Attorney shall expire as to any individual attorney-in-fact
       if such attorney-in-fact ceases to be an executive officer of the
       Company.

       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
       to be executed as of June 2,2021.


       /s/ Junlin Ho

By:
           _____________
           Junlin Ho

</PRE>

  </div>

  </div>

          <script type="text/javascript">var s_CCSWebHostingAccount = "trcgscholarrock";</script>
        <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/8336\/html","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en","themeUrl":"sites\/g\/files\/knoqqb56236\/themes\/site\/nir_pid2662"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"user":{"uid":0,"permissionsHash":"4506f7b957b4baf2488ee006e9b884f3b49293f46cfb6e03ffbb15fedba12da4"}}</script>
<script src="../../sites/g/files/knoqqb56236/files/js/js_D31miEwayYNfIODJWy2ump8i_gwklTzvOKq4eFgXiKw4996.js?scope=footer&amp;delta=0&amp;language=en&amp;theme=nir_pid2662&amp;include=eJyNjEEKgDAMBD8k9UkhTQMGSiJNRfp7ayuePHjK7jAblQIRnVdnAq8tsy_a2cnRpTKoVSH29YOF5w5__LiDkOlEqJhbN-b4bQGTRYaMh9L2Q9yLpQuf0kIl"></script>
<script src="../../../assets.adobedtm.com/898335afd880/c52ee8aa1e90/launch-5ef258dce664.min.js" crossorigin="anonymous" async integrity="sha384-9QSqHMB+yiy/V4i+d2Au+ydEWbBz4E9DqsE+oYKOnL+kj4XAZGYZxabd0P3OGHkf"></script>

  </body>
</html>
